These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20306453)

  • 1. Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care.
    McDowell SE; Coleman JJ; Evans SJ; Gill PS; Ferner RE
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):482-9. PubMed ID: 20306453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.
    Coleman JJ; McDowell SE; Evans SJ; Gill PS; Ferner RE
    Br J Clin Pharmacol; 2010 Jul; 70(1):109-17. PubMed ID: 20642553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
    Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence with treatment for hypertension in actual practice.
    Caro JJ; Salas M; Speckman JL; Raggio G; Jackson JD
    CMAJ; 1999 Jan; 160(1):31-7. PubMed ID: 9934341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
    J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
    Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of hypertension: compliance and adverse reactions in a cohort of hypertensive patients in a primary care setting.
    Mino-León D; Reyes-Morales H; Galván-Plata ME; Ponce-Monter H; Palma-Aguirre JA; Amato D; Figueras A
    Rev Invest Clin; 2007; 59(1):8-14. PubMed ID: 17569295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care.
    Halme L; Vesalainen R; Kaaja M; Kantola I;
    Am J Hypertens; 2005 Nov; 18(11):1415-20. PubMed ID: 16280273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
    Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW; Singer DE; Meigs JB
    Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
    Waeber B; Vetter W; Darioli R; Keller U; Brunner HR
    Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study.
    van Wijk BL; Avorn J; Solomon DH; Klungel OH; Heerdink ER; de Boer A; Brookhart AM
    J Hypertens; 2007 Mar; 25(3):689-97. PubMed ID: 17278986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.